Advances in immunotherapy for tuberculosis treatment.

Clinics in Chest Medicine
G ChurchyardGraham A Rook

Abstract

Immunotherapies have the potential to improve the outcome in all patients with tuberculosis (TB) including those with multidrug-resistant (MDR)-TB and extensively drug-resistant (XDR)-TB. Immunotherapy for TB may shorten duration of treatment and reduce pathology in individuals cured by chemotherapy, potentially preventing recurrence. Currently none of the available candidate agents have proof of efficacy for use in MDR-TB or XDR-TB. Further development and evaluation of existing immunotherapeutic agents is required to identify an effective agent that can be used adjunctively with chemotherapy to improve treatment outcomes for drug-susceptible TB, MDR-TB, and XDR-TB. With a range of potential immunotherapeutics, some of which have been produced to good manufacturing practice (GMP) standards and are registered for other indications in humans, the immunotherapy option should no longer be ignored.

References

Dec 1, 1994·The Journal of Clinical Investigation·M ZhangP F Barnes
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·T W RademacherR A Dwek
Mar 1, 1996·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·J D KlausnerG Kaplan
Jan 1, 1997·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·B J JohnsonG Kaplan
Jul 27, 1999·Nature·D B LowrieC L Silva
Sep 1, 1999·Clinical and Experimental Immunology·G R StewartJ E Bradley
Dec 1, 1999·Annals of the Rheumatic Diseases·L G Corral, G Kaplan
May 23, 2002·Antimicrobial Agents and Chemotherapy·Liana TsenovaGilla Kaplan
Oct 18, 2002·European Journal of Immunology·Sabrina MariottiRoberto Nisini
Dec 7, 2002·The Lancet Infectious Diseases·Claudia Orellana
Apr 19, 2003·American Journal of Respiratory and Critical Care Medicine·John L JohnsonUNKNOWN Uganda-Case Western Reserve University Research Collaboration
Nov 26, 2003·Infection and Immunity·Gilla KaplanLinda-Gail Bekker
Apr 15, 2004·Journal of Korean Medical Science·Won-Jung KohKyung Soo Lee
May 28, 2004·Journal of Child Neurology·Johan F SchoemanGilla Kaplan
Oct 27, 2004·BMC Infectious Diseases·Roberto Suárez-MéndezPedro A López-Saura
Dec 30, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mei-Ling ChenKhashayarsha Khazaie
Feb 18, 2005·The Journal of Infectious Diseases·Harriet Mayanja-KizzaUNKNOWN Uganda-Case Western Research Collaboration
Apr 16, 2005·American Journal of Respiratory and Critical Care Medicine·Suzanne VerverPaul D van Helden
Jun 29, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert S Wallis
Sep 10, 2005·American Journal of Respiratory and Critical Care Medicine·Eric NuermbergerJacques H Grosset
Sep 28, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C ReadingJ Frincke

❮ Previous
Next ❯

Citations

Oct 26, 2011·The Journal of Infectious Diseases·Victoria O KasprowiczAjit Lalvani
Oct 26, 2011·The Journal of Infectious Diseases·Jacqueline M Achkar, Elizabeth R Jenny-Avital
Mar 30, 2012·The Journal of Infectious Diseases·Michael UhlinMarkus Maeurer
Apr 27, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Keertan DhedaYing Zhang
Sep 5, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Kwok-Chiu Chang, Wing-Wai Yew
Jan 20, 2011·Journal of Immune Based Therapies and Vaccines·Dmitry A ButovSvetlana I Zaitzeva
Sep 24, 2013·PloS One·Sarah EisenCarlton A Evans
Feb 22, 2012·Immunotherapy·Mercedes Gonzalez-Juarrero
Mar 9, 2012·Expert Review of Anti-infective Therapy·Aldar S BourinbaiarGalyna A Kutsyna
Jan 7, 2014·Tuberculosis·Kerry J WelshJeffrey K Actor
Sep 30, 2010·Translational Research : the Journal of Laboratory and Clinical Medicine·Kerry J WelshJeffrey K Actor
Feb 24, 2016·Drug Discovery Today. Disease Models·Jennifer J Linderman, Denise E Kirschner
Jun 16, 2010·Tropical Medicine & International Health : TM & IH·Giovanni Battista MiglioriAlimuddin Zumla
Apr 3, 2016·Annals of Global Health·Victory Fabian Edem, Ganiyu Olatunbosun Arinola
Nov 19, 2015·BMC Systems Biology·Elsje PienaarDenise E Kirschner
May 1, 2015·Integrative Biology : Quantitative Biosciences From Nano to Macro·Jennifer J LindermanDenise E Kirschner
Jun 21, 2013·Human Vaccines & Immunotherapeutics·Yuri V EfremenkoAldar S Bourinbaiar
Jan 18, 2013·Human Vaccines & Immunotherapeutics·Carlos R Zárate-BladésCelio L Silva
Jan 12, 2013·Tuberculosis·Brenda SáenzGraciela Cárdenas
Feb 18, 2015·The Journal of Antimicrobial Chemotherapy·Rodrigo F RodriguesCelio L Silva
Sep 14, 2012·Clinical & Developmental Immunology·Kerry J WelshJeffrey K Actor
Nov 29, 2011·Journal of Infection and Public Health·Mauricio VecinoStephen E Weis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Robert S Wallis
The Journal of Infectious Diseases
Harriet Mayanja-KizzaUganda-Case Western Research Collaboration
American Journal of Respiratory and Critical Care Medicine
Adrian R MartineauChristopher J Griffiths
© 2022 Meta ULC. All rights reserved